Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)
June 11, 2024 21:13 ET
|
Opthea Limited
Financing extends Opthea’s cash runway through Phase 3 topline data readout for both pivotal trials of sozinibercept in wet AMD Phase 3 topline data readout accelerated for COAST to early Q2...
Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies
June 11, 2024 19:20 ET
|
Scilex Holding Company
PALO ALTO, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and...
Losing Talent in the Age of AI: Global Survey Finds Singapore Businesses Fail to Unlock the Full Potential of their Employees
June 11, 2024 19:00 ET
|
Kelly Services, Inc.
Businesses are failing to unlock the full potential of their employees and poor workforce planning is holding back growth for most, a Kelly survey found.
Losing Talent in the Age of AI: Global Survey Finds Businesses Fail to Unlock the Full Potential of their Employees
June 11, 2024 19:00 ET
|
Kelly Services, Inc.
Businesses are failing to unlock the full potential of their employees and poor workforce planning is holding back growth for most, a Kelly survey found.
Beamr Provides Oracle Cloud Infrastructure Customers with Ultra-Efficient, AI-ready Video Processing Solution
June 11, 2024 18:00 ET
|
Beamr Imaging Ltd.
Beamr is Powered by Oracle Cloud and Now Available in the Oracle Cloud Marketplace Herzliya, Israel, June 11, 2024 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video...
Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)
June 11, 2024 17:47 ET
|
Ultragenyx Pharmaceutical Inc.
14-month data show treatment with setrusumab resulted in a large, sustained 67% reduction in annualized fracture rate and persistent median annualized fracture rate of 0.00 (p=0.0014) Treatment...
Tonix Pharmaceuticals Announces Proposed Public Offering
June 11, 2024 17:17 ET
|
Tonix Pharmaceuticals Holding Corp.
CHATHAM, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company, today announced that it...
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 11, 2024 17:00 ET
|
Travere Therapeutics, Inc.
SAN DIEGO, June 11, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that on June 10, 2024, the Compensation Committee of its Board of Directors granted inducement...
Streamline Health® Reports Fiscal First Quarter 2024 Financial Results
June 11, 2024 16:30 ET
|
Streamline Health Solutions, Inc.
Net loss of ($2.7 million) during the first quarter of fiscal 2024 compared to net loss of ($2.9 million) during the first quarter of fiscal 2023Adjusted EBITDA improved to a loss of ($0.7 million)...
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
June 11, 2024 16:30 ET
|
Denali Capital Acquisition Corp.
NEW YORK, NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that an aggregate of $50,000 has been deposited into the...